Caleres (NYSE:CAL) Releases FY 2026 Earnings Guidance

Caleres (NYSE:CAL) issued an update on its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.500-1.650 for the period, compared to the consensus EPS estimate of 0.720. The company issued revenue guidance of -. Caleres also updated its Q3 2026 guidance to 0.620-0.700 EPS.

Caleres Trading Up 1.6%

Shares of Caleres stock opened at $12.22 on Thursday. Caleres has a 12-month low of $8.80 and a 12-month high of $16.14. The company has a market cap of $410.47 million, a P/E ratio of -1,220.78 and a beta of 0.75. The company’s fifty day simple moving average is $12.69 and its two-hundred day simple moving average is $12.43.

Caleres (NYSE:CAL) last announced its quarterly earnings results on Wednesday, September 9th. The textile maker reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.10. The company had revenue of $695.45 million for the quarter, compared to analysts’ expectations of $702.49 million. Caleres had a net margin of 0.02% and a return on equity of 7.33%. Caleres’s quarterly revenue was up 5.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.20 earnings per share. Caleres has set its Q3 2026 guidance at 0.620-0.700 EPS and its FY 2026 guidance at 1.500-1.650 EPS. Analysts predict that Caleres will post 1.62 EPS for the current fiscal year.

Caleres Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Friday, September 11th will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, September 11th. This represents a $0.28 dividend on an annualized basis and a yield of 2.3%. Caleres’s payout ratio is currently -2,800.00%.

Analyst Upgrades and Downgrades

CAL has been the topic of several recent analyst reports. Wall Street Zen downgraded shares of Caleres from a “buy” rating to a “hold” rating in a research report on Saturday, August 29th. Zacks Research cut Caleres from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 1st. KeyCorp reiterated a “sector weight” rating on shares of Caleres in a research report on Friday, June 5th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Caleres in a research report on Friday, July 31st. Two research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Caleres currently has an average rating of “Reduce”.

Caleres News Summary

Here are the key news stories impacting Caleres this week:

• Positive Sentiment: Caleres reported second-quarter adjusted EPS of $0.47, well above the $0.37 analyst consensus and up from $0.20 a year earlier. Revenue increased 5.6% year over year to $695.45 million, although it was below the $702.49 million estimate. Caleres earnings report
• Positive Sentiment: The company raised its fiscal 2026 EPS outlook to $1.50-$1.65, signaling confidence that recent operating momentum will continue. Management said its Brand Portfolio achieved broad-based gains across brands, sales channels and geographies, while gaining share in women’s fashion footwear. Caleres Reports Second Quarter 2026 Results
• Positive Sentiment: Fashion-focused brands, including pumps, flats and loafers, were key growth drivers. The results suggest Caleres is benefiting from consumer demand for its fashion brands, which management said are “resonating with consumers.” Caleres shoe sales article
• Neutral Sentiment: Caleres forecast third-quarter EPS of $0.62-$0.70, below the $0.83 consensus, but expects higher sales. This indicates stronger full-year expectations may be weighted toward later quarters rather than an immediate acceleration.
• Negative Sentiment: Revenue missed expectations, and Famous Footwear reportedly lagged the company’s fashion-brand portfolio. Continued weakness at the retail division could limit the benefit of the stronger Brand Portfolio performance. Caleres brands and Famous Footwear article

Institutional Investors Weigh In On Caleres

A number of large investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC raised its position in shares of Caleres by 143.2% in the first quarter. AQR Capital Management LLC now owns 90,546 shares of the textile maker’s stock valued at $1,560,000 after buying an additional 53,320 shares during the last quarter. Empowered Funds LLC boosted its stake in Caleres by 4.2% in the 1st quarter. Empowered Funds LLC now owns 162,814 shares of the textile maker’s stock worth $2,805,000 after buying an additional 6,502 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Caleres by 4.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 105,137 shares of the textile maker’s stock valued at $1,812,000 after acquiring an additional 4,175 shares during the last quarter. Franklin Resources Inc. raised its holdings in Caleres by 5.6% in the second quarter. Franklin Resources Inc. now owns 18,902 shares of the textile maker’s stock valued at $231,000 after buying an additional 1,007 shares during the period. Finally, Rhumbline Advisers raised its position in Caleres by 2.4% in the second quarter. Rhumbline Advisers now owns 99,677 shares of the textile maker’s stock valued at $1,218,000 after purchasing an additional 2,352 shares during the period. 98.44% of the stock is owned by institutional investors and hedge funds.

About Caleres

Caleres, Inc, formerly known as Brown Shoe Company, is a leading footwear company engaged in the design, sourcing, marketing and selling of a broad portfolio of branded and private-label shoes. The company’s operations span a range of market segments from value-priced to premium and luxury. Caleres operates through two primary segments: a retail segment anchored by the Famous Footwear banner, which includes more than 1,100 stores across North America, and a brand portfolio segment comprising owned and licensed brands such as Allen Edmonds, Naturalizer, Sam Edelman, Dr.